
The amygdala, crucial for mood, anxiety, fear, and reward regulation, shows neuroanatomical and molecular divergence in psychiatric disorders like schizophrenia, bipolar disorder and major depression. This region is also emerging as an important regulator of metabolic and immune pathways. The goal of...

Identifying the nature of mitochondrial perturbations in brain regions dysfunctional in schizophrenia (SZ) and bipolar disorder (BP) is essential to decipher their disease processes. Employing "threshold-free" analytical approaches that evaluate patterns of gene expression differences and functional...

Shared clinical features and genetic factors in schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD) have led to the hypothesis of common pathophysiological mechanisms. This study aims to elucidate aberrant transdiagnostic structural covariance patterns across these disorders...

Sleep disturbances are prevalent in bipolar disorder (BD) patients, and the circadian locomotor output cycles kaput (Clock) gene plays a significant role in this process. The role of microglia (the brain-resident immune cells) in mediating this process remains uncertain. In this study, our findings showed...

Negative symptoms of schizophrenia (SCZ), particularly amotivation, are prominent across both SCZ and bipolar disorder (BD). While orbitofrontal cortex (OFC) alterations have been implicated in the development of negative symptoms, their contributions across disorders remain to be established. Here,...